Literature DB >> 8660150

Neurological signs, aging, and the neurodegenerative syndromes.

L M Waite1, G A Broe, H Creasey, D Grayson, D Edelbrock, B O'Toole.   

Abstract

OBJECTIVES: To identify the prevalence of neurological signs said to be associated with "normal" aging in subjects 75 years and older. To examine the association of these signs with age, stroke, the neurodegenerative diagnoses (dementia, cognitive impairment, gait ataxia, gait slowing, and parkinsonism), and systemic diseases.
DESIGN: Subjects participated in a standardized clinical history, examination, neurological evaluation, and neuropsychological assessment battery. A linear regression model that allowed the simultaneous consideration of multiple parameters was used to assess the independent contribution of age and disease to the presence of the signs. Correlations between the signs and age in the subgroup free of neurological diagnoses were performed.
SETTING: Community-based study in Sydney, Australia. PARTICIPANTS: A random sample of 647 community-dwelling subjects older than 75 years. MAIN OUTCOME MEASURES: Standardized neurological examination in 537 subjects.
RESULTS: With the exception of impaired vibration sense (beta = .009, P < .01), loss of upward gaze (beta = .005, P < .01), and bradykinesia (beta = .005, P < .01), all signs were associated with the neurodegenerative syndromes and stroke. Analysis of the subgroup free of neurological diagnoses confirmed these findings. Apart from impaired vibration sense of the thumbs (r = 0.22, P < .01) and gait instability (r = 0.20, P < .05), no significant associations with age were identified.
CONCLUSION: It is not aging to which many neurological signs should be attributed, but rather to the neurodegenerative syndromes that accompany aging.

Entities:  

Mesh:

Year:  1996        PMID: 8660150     DOI: 10.1001/archneur.1996.00550060040013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

1.  Preclinical syndromes predict dementia: the Sydney older persons study.

Authors:  L M Waite; G A Broe; D A Grayson; H Creasey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

2.  Cognitive function, habitual gait speed, and late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002.

Authors:  Hsu-Ko Kuo; Suzanne G Leveille; Yau-Hua Yu; William P Milberg
Journal:  Gerontology       Date:  2006-11-06       Impact factor: 5.140

3.  Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia.

Authors:  Kenji Ishibashi; Yoshiharu Miura; Kinya Ishikawa; Ming-Rong Zhang; Jun Toyohara; Kiichi Ishiwata; Kenji Ishii
Journal:  J Neurol       Date:  2016-08-08       Impact factor: 4.849

Review 4.  Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review.

Authors:  Julia Zaccai; Paul Ince; Carol Brayne
Journal:  BMC Neurol       Date:  2006-01-09       Impact factor: 2.474

5.  Self-reported parkinsonian symptoms in the EPIC-Norfolk cohort.

Authors:  Lianna S Ishihara; Kay-Tee Khaw; Robert Luben; Sheila Bingham; Ailsa Welch; Nicholas Day; Carol Brayne
Journal:  BMC Neurol       Date:  2005-08-24       Impact factor: 2.474

6.  Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease.

Authors:  Anastazija Gnjec; Katarzyna J D'Costa; Simon M Laws; Ross Hedley; Kelvin Balakrishnan; Kevin Taddei; Georgia Martins; Athena Paton; Giuseppe Verdile; Samuel E Gandy; G Anthony Broe; William S Brooks; Hayley Bennett; Olivier Piguet; Patricia Price; Judith Miklossy; Joachim Hallmayer; Patrick L McGeer; Ralph N Martins
Journal:  J Neuroinflammation       Date:  2008-08-20       Impact factor: 8.322

7.  The neuropharmacology of (-)-stepholidine and its potential applications.

Authors:  Kechun Yang; Guozhang Jin; Jie Wu
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.